Richard Meier A.'s most recent trade in Biomarin Pharmaceutical Inc. - Registered Shares was a trade of 6,650 Common Stock done . Disclosure was reported to the exchange on May 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biomarin Pharmaceutical Inc | Richard A. Meier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 6,650 | 127,426 (0%) | 0% | 0 | Common Stock | |
| Biomarin Pharmaceutical Inc | Richard A. Meier | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.10 per share. | 03 Jun 2024 | 6,600 | 126,227 (0%) | 0% | 63.1 | 416,460 | Common Stock |
| Biomarin Pharmaceutical Inc | Richard A. Meier | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 6,600 | 0 | - | - | Stock Option (Right to Buy Common Stock) | |
| Biomarin Pharmaceutical Inc | Richard A. Meier | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.41 per share. | 03 Jun 2024 | 5,451 | 120,776 (0%) | 0% | 76.4 | 416,511 | Common Stock |
| Biomarin Pharmaceutical Inc | Richard A. Meier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 7,080 | 119,627 (0%) | 0% | 0 | Common Stock | |
| Biomarin Pharmaceutical Inc | Richard Meier A. | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Jan 2024 | 3,000 | 112,547 (0%) | 0% | 0 | Common Stock | |
| Biomarin Pharmaceutical Inc | Richard A. Meier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 4,190 | 115,547 (0%) | 0% | 0 | Common Stock | |
| Biomarin Pharmaceutical Inc | Richard A. Meier | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 67.81 per share. | 12 May 2023 | 8,500 | 117,494 (0%) | 0% | 67.8 | 576,385 | Common Stock |
| Biomarin Pharmaceutical Inc | Richard A. Meier | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2023 | 8,500 | 0 | - | - | Stock Option (Right to Buy Common Stock) | |
| Biomarin Pharmaceutical Inc | Richard A. Meier | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.93 per share. | 12 May 2023 | 6,137 | 111,357 (0%) | 0% | 93.9 | 576,448 | Common Stock |
| Biomarin Pharmaceutical Inc | Richard A. Meier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 4,980 | 108,994 (0%) | 0% | 0 | Common Stock | |
| Biomarin Pharmaceutical Inc | Richard A. Meier | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2022 | 8,500 | 0 | - | - | Stock Option (Right to buy Common Stock) | |
| Biomarin Pharmaceutical Inc | Richard A. Meier | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.46 per share. | 02 May 2022 | 8,500 | 107,892 (0%) | 0% | 37.5 | 318,410 | Common Stock |
| Biomarin Pharmaceutical Inc | Richard A. Meier | Director | Sale of securities on an exchange or to another person at price $ 82.09 per share. | 02 May 2022 | 3,860 | 104,032 (0%) | 0% | 82.1 | 316,867 | Common Stock |
| Biomarin Pharmaceutical Inc | Richard A. Meier | Director | Sale of securities on an exchange or to another person at price $ 82.11 per share. | 02 May 2022 | 18 | 104,014 (0%) | 0% | 82.1 | 1,478 | Common Stock |
| Biomarin Pharmaceutical Inc | Richard A. Meier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 5,120 | 99,392 (0%) | 0% | 0 | Common Stock |